EP 4349861 A1 20240410 - BISPECIFIC BINDING MOLECULE BINDING VEGF AND ANG2 AND USE THEREOF
Title (en)
BISPECIFIC BINDING MOLECULE BINDING VEGF AND ANG2 AND USE THEREOF
Title (de)
BISPEZIFISCHES BINDEMOLEKÜL ZUR BINDUNG VON VEGF UND ANG2 UND VERWENDUNG DAVON
Title (fr)
MOLÉCULE DE LIAISON BISPÉCIFIQUE SE LIANT AU VEGF ET À L'ANG2 ET SON UTILISATION
Publication
Application
Priority
- CN 202110623779 A 20210604
- CN 2022096848 W 20220602
Abstract (en)
The present invention relates to an antibody directed against a vascular endothelial growth factor (VEGF/VEGF-A) and angiopoietin-2 (ANG-2), respectively, a bispecific binding molecule (e.g., an antibody) directed against the vascular endothelial growth factor (VEGF/VEGF-A) and angiopoietin-2 (ANG-2) simultaneously, a preparation method therefor, a pharmaceutical composition comprising the antibody or molecule, and use thereof.
IPC 8 full level
C07K 16/22 (2006.01); C07K 16/26 (2006.01)
CPC (source: EP KR)
A61P 27/02 (2018.01 - KR); C07K 16/22 (2013.01 - EP KR); C07K 16/26 (2013.01 - EP); C12N 15/70 (2013.01 - EP KR); A61K 2039/505 (2013.01 - KR); C07K 2317/31 (2013.01 - KR); C07K 2317/569 (2013.01 - KR); C07K 2317/622 (2013.01 - KR); C07K 2317/76 (2013.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
EP 4349861 A1 20240410; AU 2022287100 A1 20240125; CA 3221192 A1 20221208; CN 117500828 A 20240202; IL 309035 A 20240201; JP 2024520693 A 20240524; KR 20240023095 A 20240220; TW 202302633 A 20230116; WO 2022253314 A1 20221208
DOCDB simple family (application)
EP 22815354 A 20220602; AU 2022287100 A 20220602; CA 3221192 A 20220602; CN 2022096848 W 20220602; CN 202280039743 A 20220602; IL 30903523 A 20231203; JP 2023574547 A 20220602; KR 20247000079 A 20220602; TW 111120663 A 20220602